Why finding COVID-19 vaccine won't be enough to end pandemic

Medical experts have warned that the volume of vaccine available to fight the coronavirus or SARS-CoV-2 in coming years is expected to fall far short of global demand, despite an unprecedented......

Covid Vaccine IP: How Big Pharma lobbied against India

Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual......

Sanofi extends USD 18.5 bn bid for Genzyme

Sanofi-aventis on Mondaysaid it has extended its $18.5 billion offer for Genzyme for the second time, a move that will give the French drug-maker additional time to reach an agreement with US......

Dengue drug can give Sanofi $1-bn India biz

French drug major Sanofi’s dengue vaccine discovery could open a $-1 billion opportunity in India alone. The Paris-based global drug giant announced last week that it would have the vaccine......

Sanofi Pasteur to bring first dengue vaccine to India

The French drug maker has its vaccine approved in Mexico for all four serotypes for patients aged 9 to 45. Sanofi Pasteur, the vaccine division of drug maker Sanofi, has completed the first study......

Will retire from the chairmanship of Sanofi India: Mallya

Vijay Mallya left the country earlier this month amid continuing efforts by banks to recover dues totalling over Rs 9,000 crore. Beleaguered liquor baron Vijay Mallya on Wednesday announced he will......